Bluebook
Pharma Services April 2019
2019 - April: Report on M&A and financing activity in the pharma services drug development industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
- Transactions in the Pharma Services – Development industry totaled five mergers & acquisitions and two financings during the month of April
- The Laboratory Services sector was the most active this month, with 2 M&A transactions and 2 financings
- Total disclosed M&A value was $485.0 million, while financings totaled $2.2 million during the month of April
- The largest disclsoed M&A transaction this month was the $485 million acquisition of Envigo’s Nonclinical Research Services by Covance Inc., while the largest financing this month was $1.5 million by AKESOgen, Inc.
- M&A and financings in the United States accounted for 60% and 50% of total transactions this month, down 28% and 50%, respectively
- M&A activity this month includes acquisitions by TriNetX, Protagen Protein Services, and Evolution Research Group